CAXTON ADVANTAGE LIFE SCIENCES FUND
Caxton Advantage Life Science Fund is a New York-based financial firm that invests into companies in the life-science field.
CAXTON ADVANTAGE LIFE SCIENCES FUND
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Register.com DNS Network Solutions
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-11-20 | VIVUS | Caxton Advantage Life Sciences Fund investment in Post-IPO Equity - VIVUS | 33.6 M USD |
| 2014-08-04 | Mevion Medical Systems | Caxton Advantage Life Sciences Fund investment in Private Equity Round - Mevion Medical Systems | 200 M USD |
| 2013-06-25 | Mevion Medical Systems | Caxton Advantage Life Sciences Fund investment in Private Equity Round - Mevion Medical Systems | 55 M USD |
| 2012-12-17 | Regado Biosciences | Caxton Advantage Life Sciences Fund investment in Series E - Regado Biosciences | 51 M USD |
| 2010-08-24 | Gemin X Pharmaceuticals | Caxton Advantage Life Sciences Fund investment in Series E - Gemin X Pharmaceuticals | 8 M USD |
| 2010-04-20 | Gemin X Pharmaceuticals | Caxton Advantage Life Sciences Fund investment in Series D - Gemin X Pharmaceuticals | 16 M USD |
| 2009-12-17 | Regado Biosciences | Caxton Advantage Life Sciences Fund investment in Series D - Regado Biosciences | 40 M USD |
| 2009-04-07 | Sunesis Pharmaceuticals | Caxton Advantage Life Sciences Fund investment in Post-IPO Equity - Sunesis Pharmaceuticals | 43.5 M USD |
| 2009-01-01 | Mevion Medical Systems | Caxton Advantage Life Sciences Fund investment in Venture Round - Mevion Medical Systems | 33 M USD |
| 2008-08-14 | Anthera Pharmaceuticals | Caxton Advantage Life Sciences Fund investment in Venture Round - Anthera Pharmaceuticals | 19 M USD |
More informations about "Caxton Advantage Life Sciences Fund"
Caxton Advantage Life Sciences Fund - Crunchbase
Caxton Advantage Life Science Fund is a New York-based financial firm that invests into companies in the life-science field. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Caxton Advantage Life Sciences Fund I: Performance - PitchBook
Jan 1, 2006 Caxton Advantage Life Sciences Fund I is a 2006 vintage venture capital fund managed by Valence Life Sciences. The fund is located in New York, New York. The fund …See details»
USA Directors - ASF
We are a world-leading science and advocacy organization with headquarters in New Brunswick, Canada. We have several directors that help guide the organization. ... Eric Roberts co-founded Valence Advantage Life Sciences …See details»
Eric Roberts - ASF
Eric Roberts co-founded Valence Advantage Life Sciences and the Caxton Advantage Life Sciences Fund. Mr. Roberts has 37 years of experience in the investment banking and private …See details»
Caxton Advantage Life Science Fund LP - Company Profile and News
Company profile page for Caxton Advantage Life Science Fund LP including stock price, company news, executives, board members, and contact informationSee details»
About Us - CalciMedica
In 2012, Mr. Roberts co-founded the investment firm, Valence Life Sciences. Prior to Valence Life Sciences, Mr. Roberts managed the Caxton Advantage Life Sciences Fund which he co-founded in 2005. Prior to Caxton Advantage, he …See details»
Caxton Advantage Life Sciences Fund, L.P. – Fund Data - Private …
Caxton Advantage Life Sciences Fund, L.P. is a venture capital fund operated by Valence Life Sciences, Llc and has approximately $19.7 million in assets. There is currently no minimum …See details»
Caxton Advantage Life Sciences Fund - Crunchbase
Caxton Advantage Life Science Fund is a New York-based financial firm that invests into companies in the life-science field.See details»
Caxton Advantage Life Sciences Fund - Investor Profile: Portfolio ...
Caxton Advantage Life Sciences Fund. Headquarters New York, New York. Classification Investor. Overview ...See details»
Valence Life Sciences
In 2012, Mr. Roberts co-founded investment firm, Valence Life Sciences. Prior to Valence Life Sciences, Mr. Roberts managed the Caxton Advantage Life Sciences Fund which he co …See details»
Caxton Advantage Venture Partners Announces Formation of …
Feb 23, 2012 The investment team currently manages Caxton Advantage Life Sciences Fund. CONTACT: Investor Relations: The Trout Group Brian Korb [email protected] 646-378-2923. …See details»
PRESS RELEASE: Corthera Closes $23 Million Financing Round
Dec 20, 2007 New investor Caxton Advantage Life Sciences Corthera Closes $23 Million Financing Round SAN MATEO, Calif., Dec. 20 - Corthera Inc. today announced it has closed a …See details»
Corthera pockets $23M in VC, names CEO - Fierce Biotech
Dec 20, 2007 Caxton Advantage Life Sciences Fund joined A-list life science investors Domain Associates and Kleiner, Perkins, San Mateo, CA-based Corthera has closed a $23 million third …See details»
Corthera Closes $23 Million Financing Round - BioSpace
SAN MATEO, Calif., Dec. 20 /PRNewswire/ -- Corthera Inc. today announced it has closed a $23 million Series C financing. New investor Caxton Advantage Life Sciences Fund, a fund …See details»
Anthera garners $19M in new venture funds | Fierce Biotech
Aug 13, 2008 New investors Caxton Advantage Life Sciences Fund and HBM Anthera Pharmaceuticals has completed a $19 million venture round and plans to use the funds to …See details»
Gemin X Pharmaceuticals, Inc. Announces $16 Million Series D
Apr 20, 2010 MALVERN, Pa. & MONTRÉAL--(BUSINESS WIRE)--Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, …See details»
Regado gains $23M in financing | Fierce Biotech
Mar 27, 2007 Regado Biosciences has landed $23 million in Series C financing. New investor Caxton Advantage Life Sciences Fund, Domain Associates and Quaker BioVentures led the …See details»
Caxton Advantage Venture Partners - Crunchbase
Caxton Advantage Venture Partners is a life sciences venture firm that specializes in late-stage private and public drug development firms. ... Caxton Advantage Venture Partners . Connect …See details»
Valence Life Sciences investment portfolio | PitchBook
Jun 15, 2015 Information on investments, active portfolio, exits, fund performance, dry powder, and co-investors for Valence Life Sciences. Use the PitchBook Platform to explore the full profile.See details»